BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32107752)

  • 1. Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.
    Kopruszinski CM; Swiokla J; Lee YS; Navratilova E; VanderVeen L; Yang M; Liu Y; Miyazaki T; Schmidt WK; Zalevsky J; Porreca F
    Cell Mol Neurobiol; 2021 Jul; 41(5):949-960. PubMed ID: 32107752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
    Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
    J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
    Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
    Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
    Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
    Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice.
    Lowery JJ; Raymond TJ; Giuvelis D; Bidlack JM; Polt R; Bilsky EJ
    J Pharmacol Exp Ther; 2011 Mar; 336(3):767-78. PubMed ID: 21118955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
    Walker EA; Young AM
    Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.
    Peckham EM; Traynor JR
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1195-201. PubMed ID: 16291875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
    Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
    Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential.
    Miyazaki T; Choi IY; Rubas W; Anand NK; Ali C; Evans J; Gursahani H; Hennessy M; Kim G; McWeeney D; Pfeiffer J; Quach P; Gauvin D; Riley TA; Riggs JA; Gogas K; Zalevsky J; Doberstein SK
    J Pharmacol Exp Ther; 2017 Oct; 363(1):104-113. PubMed ID: 28778859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats. Influence of nociceptive intensity and intrinsic efficacy at the mu receptor.
    Smith MA; Gray JD
    Psychopharmacology (Berl); 2001 Aug; 156(4):445-53. PubMed ID: 11498722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
    Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive and Discriminative Stimulus Effects of Six Novel Psychoactive Opioid Substances in Male Rats.
    Walker EA; Chambers C; Korber MG; Tella SR; Prioleau C; Fang L
    J Pharmacol Exp Ther; 2021 Oct; 379(1):1-11. PubMed ID: 34244232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats.
    Austin Zamarripa C; Edwards SR; Qureshi HN; Yi JN; Blough BE; Freeman KB
    Drug Alcohol Depend; 2018 Nov; 192():158-162. PubMed ID: 30261403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
    Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
    Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
    Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
    Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury.
    Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
    Neurosci Lett; 1995 Oct; 199(2):83-6. PubMed ID: 8584249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
    Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F
    Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.